| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.08▼ | 3.09▼ | 3.07▼ | 3.00▲ | 2.61▲ |
| MA10 | 3.09▼ | 3.05▲ | 3.03▲ | 2.91▲ | 2.55▲ |
| MA20 | 3.09▼ | 3.02▲ | 2.99▲ | 2.55▲ | 3.82▼ |
| MA50 | 3.02▲ | 2.97▲ | 2.93▲ | 2.65▲ | 5.95▼ |
| MA100 | 2.99▲ | 2.93▲ | 2.73▲ | 4.09▼ | N/A |
| MA200 | 2.94▲ | 2.65▲ | 2.44▲ | 5.66▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | 0.007▲ | 0.007▲ | 0.086▲ | 0.058▲ |
| RSI | 45.454▼ | 54.439▲ | 55.373▲ | 58.895▲ | 38.667▼ |
| STOCH | 26.263 | 84.390▲ | 69.234 | 77.150 | 40.018 |
| WILL %R | -62.500 | -36.585 | -30.000 | -12.845▲ | -58.766 |
| CCI | -245.778▼ | 18.527 | 57.816 | 84.771 | -7.071 |
| CDL | $ACTU Doji Candlestick Pattern Detected | Set Alert |
|
Wednesday, May 06, 2026 05:50 AM
Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/05/26 | 3.045 | 3.125 | 2.92 | 3.05 | 95,669 |
| 05/05/26 | 2.98 | 3.08 | 2.8101 | 3.07 | 38,648 |
| 04/05/26 | 2.98 | 3.055 | 2.91 | 2.95 | 48,686 |
| 01/05/26 | 2.94 | 3.1299 | 2.8501 | 3.00 | 93,575 |
| 30/04/26 | 2.85 | 2.9577 | 2.7612 | 2.94 | 87,299 |
| 29/04/26 | 2.79 | 2.97 | 2.6411 | 2.88 | 102,236 |
| 28/04/26 | 2.80 | 3.185 | 2.75 | 2.90 | 117,237 |
| 27/04/26 | 2.99 | 3.19 | 2.78 | 2.85 | 236,925 |
| 24/04/26 | 2.54 | 3.09 | 2.48 | 2.97 | 283,300 |
| 23/04/26 | 2.80 | 2.9499 | 2.4101 | 2.53 | 201,660 |
|
|
||||
|
|
||||
|
|